The goal of the Transmission of Oncogenic HPV Infection Among Families (TREVINO) study is to improve understanding of how high-risk human papillomavirus (HPV) infections are transmitted within families. The research focuses on transmission between sexual partners and between parents and children. It also examines how the various microbes may influence the persistence of HPV infections and the development of HPV-related cancers.
The study will include up to 300 couples recruited from gynecology and ear, nose, and throat (ENT) clinics in Finland, as well as their children. Participants include individuals with persistent HPV infection, cervical precancer or cancer, or HPV-related head and neck cancer, along with their partners and potentially their offspring.
Participants will provide self-collected samples from the oral and genital areas at multiple time points over up to five years. Questionnaires addressing medical, behavioural, and environmental factors will be completed.
The study is conducted at Tampere University Hospital and Kuopio University Hospital in Finland. Results will inform HPV screening and prevention programs, improve understanding of family-level transmission, and identify potential microbial and genetic markers linked to cancer risk.
Patient with colposcopy clinic detected persisting HR-HPV infection
Patient with diagnosed cervical cancer
Patient with diagnosed OSCC
Patients' sexual partners of women or men that are referred to the colposcopy/gynecological oncology/ENT
Candidate who don't speak Finnish
Patients who will be attending either the ObGyn or ENT at Tampere University Hospital (TAUH) or at Kuopio University Hospital (KUH) concerning HPV associated decease and their spouses and offspring.
Cohort
Prospective
Not listed
HPV genotype among patients with HPV associated disease and their sexual couples
All oral and genital samples are genotypes using extended HPV genotyping assays that detect at least 25 different HPV genotypes separately.
Click on the lead sponsor to view all of their trials.
Tampere University Hospital
Lead sponsor
Kuopio University Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
